Chan Kk
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Ovarian cancer diagnosis and treatment 4
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- George R. P. Blackledge (4 shared papers)Frank Lawton (3 shared papers)Rowan T. Chlebowski (2 shared papers)Jerome B. Block (1 shared paper)Mark Y. Tong (1 shared paper)ERIC WATSON (2 shared papers)Kenneth J. Himmelstein (1 shared paper)J R BATEMAN (1 shared paper)
- Journals
- The Pharmacogenomics Journal (1 paper)Cochrane Database of Systematic Reviews (1 paper)PubMed (12 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Chan Kk
14 papers receiving 427 citations
Peers
Comparison fields: 5 of 51
- Reproductive Medicine 127
- Hepatology 82
- Pharmacology 62
- Otorhinolaryngology 28
- Toxicology 20
Countries citing papers authored by Chan Kk
This map shows the geographic impact of Chan Kk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Kk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Kk more than expected).
Fields of papers citing papers by Chan Kk
This network shows the impact of papers produced by Chan Kk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Kk. The network helps show where Chan Kk may publish in the future.
Co-authors
The 25 scholars most cited alongside Chan Kk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. | 1984 | 95 |
| 2 | Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. | 1989 | 88 |
| 3 | Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. | 1978 | 74 |
| 4 | The CSROC Expert Panel. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy | 2010 | 41 |
| 5 | Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols. | 1973 | 38 |
| 6 | Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases. | 1984 | 32 |
| 7 | 2005 | 29 | |
| 8 | Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner. | 1976 | 22 |
| 9 | Metabolism of methotrexate in man after high and conventional doses. | 1980 | 16 |
| 10 | High-presssure liquid chromatographic determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, in human plasma. | 1978 | 13 |
| 11 | A fluorometric determination of adriamycin and its metabolites in biological tissues. | 1973 | 10 |
| 12 | A pilot study on early post-operative morbidity and technique of inguinal node dissection in vulval carcinoma. | 1998 | 9 |
| 13 | Survival after negative second-look laparotomy. | 1989 | 8 |
| 14 | Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer. | 1986 | 5 |
About Chan Kk
Chan Kk is a scholar working on Reproductive Medicine, Pharmacology, Analytical Chemistry, Otorhinolaryngology and Hepatology, having authored 14 papers that have together received 480 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Cancer therapeutics and mechanisms (1 paper), Drug Transport and Resistance Mechanisms (1 paper), Head and Neck Cancer Studies (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Reproductive Medicine (127 citations), Hepatology (82 citations), Pharmacology (62 citations), Otorhinolaryngology (28 citations) and Toxicology (20 citations). Chan Kk has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include George R. P. Blackledge, Frank Lawton, Rowan T. Chlebowski, Jerome B. Block, Mark Y. Tong, ERIC WATSON, Kenneth J. Himmelstein, J R BATEMAN, William F. Trager and Jan Clarkson. Their work appears in journals such as The Pharmacogenomics Journal, Cochrane Database of Systematic Reviews and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.